MARKET

AIMDW

AIMDW

AINOS INC
NASDAQ
0.1160
0.0000
0.00%
Closed 09:30 03/27 EDT
OPEN
0.1160
PREV CLOSE
0.1160
HIGH
0.1160
LOW
0.1160
VOLUME
0
TURNOVER
--
52 WEEK HIGH
0.9490
52 WEEK LOW
0.0570
MARKET CAP
--
P/E (TTM)
-0.0271
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AIMDW last week (0316-0320)?
Weekly Report · 6d ago
Ainos signs deployment of 1,400 AI Nose systems in backend semiconductor environments
Reuters · 03/19 12:04
Weekly Report: what happened at AIMDW last week (0309-0313)?
Weekly Report · 03/16 09:48
Ainos plans 200 AI Nose deployments in front-end wafer fabs in 1Q26
Reuters · 03/12 12:31
Ainos to deploy about 200 AI Nose systems in front-end wafer fabs in Q1 2026
Reuters · 03/09 12:30
Weekly Report: what happened at AIMDW last week (0302-0306)?
Weekly Report · 03/09 09:49
Ainos Confirms Initial Order for 1,400 AI Nose Systems Under Three-Year Subscription Deal
Reuters · 03/02 13:30
Weekly Report: what happened at AIMDW last week (0223-0227)?
Weekly Report · 03/02 09:49
More
About AIMDW
Ainos, Inc. is a diversified healthcare company, which is focused on the development of point-of-care testing (POCT), low-dose VELDONA interferon therapeutics and synthetic Ribonucleic Acid (RNA)-driven preventative medicine. The Company's products include VELDONA clinical-stage human therapeutics, VELDONA Pet cytoprotein health supplements, and telehealth-friendly POCTs powered by its AI Nose technology platform. VELDONA Pet is formulated to address a variety of health issues in dogs and cats, including skin, gum, emotion, discomfort caused by allergies, eye, and weight-related issues. Its pipeline of products, which are under development, includes VELDONA human drugs, VOC POCT-Ainos Flora, VOC platform-NISD co-development, VOC POCT-Ainos Pen, VOC POCT-CHS430 and Synthetic RNA. VELDONA human drugs are the high-priority programs include oral warts for human immunodeficiency virus seropositive patients, common cold, influenza, Sjogrens syndrome and treatment for mild COVID-19 symptoms.

Webull offers Ainos Inc stock information, including NASDAQ: AIMDW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AIMDW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AIMDW stock methods without spending real money on the virtual paper trading platform.